Atlas Trials

Efficacy of Double vs Standard Empapagliflozin Dose for METabolic syndromE tReatment

Clinical trial NCT05905965 · RECRUITING

Trial details

NCT number
NCT05905965
Sponsor
Collegium Medicum w Bydgoszczy
Status
RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
Metabolic Syndrome
Start date
2023-05-01
Primary completion
2025-12-31
Enrollment
200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.